Skip to content

Study · Randomized controlled trial · n = 16 · 1995

1 result

Pre-ovulatory oxytocin administration promotes the onset of the luteinizing hormone surge in human females.

Hull ML, Reid RA, Evans JJ, Benny PS, Aickin DR

Human reproduction (Oxford, England)1 Sept 1995Cited by 12 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In women with natural ovulatory cycles, a late follicular oxytocin infusion brought the onset of the LH surge earlier than normal saline.

    In plain wordsIn women, oxytocin given before ovulation made the luteinizing hormone surge start earlier than saline did.

    Peptide
    Oxytocin
    Outcome
    DecreaseOnset of the LH surge
    Study

    n = 16

    Comparator
    Normal saline
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    256 mIU/min · infusion · 2 hAs given in this study (human).

    Source sentences

    Summary
    The women who were administered oxytocin at this late follicular stage had an earlier onset of the LH surge than those who had received saline (P < 0.01).
    2 context sentences
    Summary · context
    In this study the effect of a preovulatory infusion of oxytocin on the onset of the LH surge was investigated in women aged 20-35 years who had natural ovulatory menstrual cycles of lengths between 25-35 days.
    Summary · context
    One group (n = 8) received an oxytocin infusion of 256 mIU/min for 2 h, the other group (n = 8) received normal saline.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.